Pune, India -- (SBWIRE) -- 08/29/2018 -- Market Insights

The global protein assays market is estimated to showcase a strong CAGR of 10.8 % over the assessment period (2017-2023), owing to the growing investment by biotech and pharma companies in R&D, asserts Market Research Future (MRFR). Protein assay is an analytical technique which is used to measure the concentration of protein in a solution. Protein assays are used in life science research to detect the presence of protein in a sample. Use of protein assays for early diagnosis of HIV and cancer might reduce the mortality and morbidity of the disease. They are reproducible, facile, and cost-effective.

Send An Enquiry @ https://www.marketresearchfuture.com/sample_request/5091

Drivers and Constraints

Assays used to diagnose HIV and cancer are cost-effective and facile. The most commonly used protein assays are Lowry, Bradford, BCA, and UV spectroscopic protein assays. Use of such assays in the diagnosis of diseases, drug discovery and development further encourages the pharmaceutical and biotechnology industry to invest in research and development activities which propels the market growth during the review period. Various biomarker identification systems are launched by market giants which offer opportunity for the market globally. For instance, Gyros Protein Technologies AB, in June 2017, launched a new version of anti-drug antibody solution for immunogenicity market. The solution allows the customers to run the assay by using small volumes of reagents and patient samples and shorten run-times.

On the flip side, high cost associated with multiplex assay hardware is inhibiting the protein assay market growth over the assessment period. Also, low research and development yields and lack of trained resources are expected to restrain the market growth in the coming years.

Global Protein Assays Market: Segmental Analysis

The global protein assays market has been segmented based on application, type, technology, product, and end-users.

By mode of type, the protein assays market has been segmented into test strip-based assays, copper-ion-based assays, dye-binding assays, and others.

By mode of application, the global protein assays market has been segmented into protein purification, diagnosis, drug discovery, and others.

By mode of product, the protein assays market has been segmented into instruments, reagents and kits, and others.

By mode of technology, the protein assays market has been segmented into colorimetric-based protein assays, absorbance-based protein assays, and fluorescence-based protein assays.

By mode of end-user, the protein assays market has been segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes, and others.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/5091

Regional Insights

Geographically, the protein assays market spans across Europe, America, Asia Pacific, and the Middle East.

Among all the regions, North America is predicted to largest market share owing to the presence of strong research and development base, emphasis on disease prevention, strong regional economics, and wellness by the government.

The European market for protein assay is also estimated to showcase a rapid growth due to the investment in various governments and privately funded R&D programs along with the increased expense of biotech and pharmaceutical industry development.

In the Asia Pacific region, countries like Japan, India, and China are poised to be promising markets over the assessment period. Expenditure on healthcare has risen in Asia owing to the growing affluence of population and the extension of state health care programs.

The Middle East region is estimated to grow at a faster pace owing to extensive development of healthcare infrastructure and emphasis on R&D development in the healthcare sector.

Industry News

The emergence of low-cost next-generation sequencing technology has enabled researchers to add single-cell genomics tools like the BD Rhapsody single cell analysis system to their labs. These tools make single-cell analysis more accessible. The BD Rhapsody system includes instruments, reagents, software, and targeted gene panels and also offers additional single-cell analysis capabilities with the BD AbSeq assay. This enables researchers to develop a complete picture of the role genes, and proteins play in biological systems.

Competitive Analysis

Some of the major market players operating the global market are Illumina Inc. (U.S.), Promega Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Abcam plc (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd (Switerzland), Lonza Group Ltd. (Switerzland), Takara Bio Inc. (Japan), Bio-Techne (U.S.), BioVision Inc. (U.S.), Cell Signaling Technology Inc. (U.S.), GE Healthcare (U.S.), QIAGEN (Germany), Thermo Fisher Scientific (U.S.), New England Biolabs (U.S.), PerkinElmer Inc. (U.S.), Lucigen Corporation (U.S.), and others.

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/5091

About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.